India's pharma stocks fall as Trump outlines steep tariffs on generic drug imports

** India's pharma stocks fall in morning trading

** U.S. President Donald Trump says imported generic drugs will remain tariff-free for two years from August 1, before tariffs increase to 100% for one year and 200% thereafter

** Nifty Pharma Index .NIPHARM down 1.01% amid a 0.7% decline in Nifty 50 Index .NSEI

** Shares of Aurobindo Pharma ARBN.NS down 2.9%, Sun Pharmaceutical SUN.NS down 1.2%, Cipla CIPL.NS down 2%, Lupin LUPN.NS falls 3%, Glenmark Pharmaceuticals GLEN.NS dips 2.6%

** Shares of Dr. Reddy's Laboratories REDY.NS fall 1.4%, Zydus Lifesciences ZYDU.NS down 2.4% and Torrent Pharmaceuticals TORP.NS down 0.8%